ArticlePharmaceutical medicine2017
Analysis of Safety-Related Regulatory Actions for New Drugs in Japan by Nature of Identified Risks.
Makoto Fujikawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it